[Federal Register Volume 73, Number 61 (Friday, March 28, 2008)]
[Notices]
[Pages 16684-16685]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E8-6433]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Meeting of the National Vaccine Program Office on Vaccine 
Financing

AGENCY: Department of Health and Human Services, Office of the 
Secretary.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Department of Health and Human Services (DHHS) is hereby 
giving notice that the National Vaccine Program Office (NVPO) will 
convene a meeting of the Vaccine Finance Working Group and is inviting 
input from stakeholders on this issue. The meeting will be open to the 
public.

DATES: The meeting will be held on Tuesday, April 29, 2008 and 
Wednesday, April 30, 2008. The meeting will be held from 9 a.m. to 5 
p.m. on both days.

ADDRESSES: Hilton Washington DC/Rockville Hotel and Executive Meeting 
Center; 1750 Rockville Pike, Rockville, MD 20852-1699.

FOR FURTHER INFORMATION CONTACT: Angela Shen, National Vaccine Program 
Office, Department of Health and Human Services, Room 443-H, Hubert H. 
Humphrey Building, 200 Independence Avenue, SW., Washington, DC 20201; 
(202) 260-1587, or e-mail [email protected].

SUPPLEMENTARY INFORMATION: NVPO has responsibility for coordinating and 
ensuring collaboration among the many Federal agencies involved in 
vaccine and immunization activities. The NVPO provides leadership and 
coordination among Federal agencies, as they work together to carry out 
the goals of the National Vaccine Plan. The National Vaccine Plan 
provides a framework, including goals, objectives, and strategies, for 
pursuing the prevention of infectious diseases through immunizations. 
NVPO periodically convenes working groups to address specific issues 
and topics that impact vaccine and immunization.
    The Vaccine Finance Working Group was established to address issues 
related to vaccine financing in the United States. The Working Group 
has developed a draft white paper with a number of policy options to be 
considered for presentation to the National Vaccine Advisory Committee 
(NVAC) for discussion. NVPO has charged the Vaccine Finance Working 
Group to obtain input from stakeholders whose viewpoints and interests 
can help shape an understanding of the issues that are relevant to the 
challenges in creating optimal approaches to vaccine financing in both 
the public and private sectors.
    The two-day meeting is scheduled to be held to provide an 
opportunity for vaccine financing stakeholders to discuss and make 
comments on the draft white paper and to solicit input, in particular, 
regarding the conclusions and options made by the working group that 
are contained in the draft document. A wide range of stakeholders 
representing health care providers, employers, payers, health insurers, 
vaccine manufacturers and distributors, consumers, and other interested 
parties within the public health community are invited to attend the 
meeting. Members of the public will have the opportunity to provide 
comments at the meeting. Public comment will be limited to five minutes 
per speaker. Any members of the public who wish to have printed 
material distributed to meeting

[[Page 16685]]

participants should submit materials to the NVPO staff person 
designated as the contact for additional information. All materials 
should be submitted to the designated point of contact no later than 
close of business April 21, 2008. Pre-registration is required for 
public comment. Any individual who wishes to participate in the public 
comment session should e-mail [email protected] or call 202-690-5566.
    There is limited space available for the public to attend this 
meeting. However, it is desired that the public participate in the 
discussions, as well. Registration is required to attend the meeting; 
registration information can be found at: https://nvpo.constellagroup.com. Registration for the meeting will be accepted 
until April 5, 2008. Registration after that date will be on the basis 
of space availability. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should notify the designated contact person.

    Dated: March 24, 2008.
Bruce Gellin,
Director, National Vaccine Program Office.
 [FR Doc. E8-6433 Filed 3-27-08; 8:45 am]
BILLING CODE 4150-44-P